The capacity of herpes simplex virus type 1 (HSV-1) to replicate in vitro decreases tremendously when animal cell cultures are exposed to ligands of both the alpha/beta interferon (IFN-a/b) receptor and IFN-c receptor prior to inoculation with low m.o.i.s of HSV-1. However, the available evidence provides no insight into the possible mechanisms by which co-activation of the IFN-a/b-and IFN-c-signalling pathways produces this effect. Therefore, it has not been possible to differentiate between whether these observations represent an important in vitro model of host immunological suppression of HSV-1 infection or an irrelevant laboratory phenomenon. Therefore, the current study was initiated to determine whether co-activation of the host cell's IFN-a/b and IFN-c pathways either (i) induced death of HSV-1-infected cells such that virus replication was unable to occur; or (ii) disrupted one or more steps in the process of HSV-1 replication. To this end, multiple steps in HSV-1 infection were compared in populations of Vero cells infected with HSV-1 strain KOS (m.o.i. of 2?5) and exposed to ligands of the IFN-a/b receptor, the IFN-c receptor or both. The results demonstrated that IFN-b and IFN-c interact in a synergistic manner to block the efficient synthesis of viral DNA and nucleocapsid formation in HSV-1-infected cells and do so without compromising host-cell viability. It was inferred that IFN-mediated suppression of HSV-1 replication may be a central mechanism by which the host immune system limits the spread of HSV-1 infection in vivo.
INTRODUCTION
Co-activation of the alpha/beta interferon (IFN-a/b)-and IFN-c-signalling pathways produces a block in herpes simplex virus type 1 (HSV-1) replication of a magnitude that is not attainable with IFN-a/b or IFN-c alone, and this effect is not cell type-, species-or virus strain-specific (Balish et al., 1992; Chen et al., 1994; . This observation has important ramifications because it suggests a previously unrecognized mechanism by which two cytokines of the immune system may cooperate to control HSV-1 infection non-cytolytically in vivo. Given that IFN-a/b and IFN-c also act potently in concert to inhibit varicella-zoster virus (Desloges et al., 2005) , human cytomegalovirus (Sainz et al., 2005) and the severe acute respiratory syndromeassociated coronavirus (Sainz et al., 2004) , the proposed interaction between the IFN-a/b-and IFN-c-signalling pathways may be of general importance in host control of viral infections.
The available evidence indicates that an interaction between the IFN-a/b-and IFN-c-signalling pathways is functionally relevant in host control of HSV-1 infections. Recent comparisons in knockout mice demonstrated that mice that lacked both IFN-a/b receptors and IFN-c receptors (IFN-a/ bR 2/2 and IFN-cR 2/2 ) were profoundly impaired in their resistance to HSV-1 strain KOS infection, experienced systemic viral spread and died 4-6 days after footpad inoculation (Luker et al., 2003; Vollstedt et al., 2004) . This phenotype is in stark contrast to single-receptor knockout mice (IFN-a/bR 2/2 or IFN-cR 2/2 ), which retain their capacity to limit HSV-1 spread and often survive infection with the KOS strain, despite the absence of one of the two IFN receptors (Luker et al., 2003) . Whilst these in vivo studies have established that loss of both IFN receptors has a catastrophic effect on host defence against HSV-1, they provide only limited insight into how the IFN-a/b and IFN-c pathways normally interact to control the spread of HSV-1 infection.
The nature of the block in HSV-1 replication produced by IFN-a/b and IFN-c remains undefined. Does exposure to IFN-a/b and IFN-c cause host cells to undergo apoptosis upon HSV-1 infection (Park et al., 2004; Takaoka et al., 2003) ? The low-multiplicity design of previous in vitro studies does not exclude this possibility (Balish et al., 1992; Chen et al., 1994; . Alternatively, IFNb and IFN-c may create a block in HSV-1 replication that does not compromise the viability of the host cell. If so, then at which step(s) between immediate-early (IE) mRNA transcription and virion egress does the inhibitory block occur? There are no published studies that address these questions.
The current study was initiated to refine our understanding of how co-activation of the IFN-a/b-and IFN-csignalling pathways prevents HSV-1 replication in vitro. Given the complexity of the HSV-1 replication cycle, we thought it unrealistic to test the scores of hypotheses that might explain the inhibitory effect sequentially. Rather, we felt that a more directed approach was first to constrain the number of possible explanations by determining whether IFN-b and IFN-c are (i) cytotoxic to HSV-1 infected cells or (ii) disrupt HSV-1 replication at one or more discernible steps relative to viral mutants or an inhibitor of viral DNA synthesis. By using this approach, the separate versus combined effects of IFN-b and IFN-c on viral DNA, mRNA, protein and virion accumulation were compared in Vero cells infected with 2?5 p.f.u. per cell of HSV-1. The use of an m.o.i. that infected nearly 100 % of cells in the population ensured that any differences in the measured parameters were the result of a defect in the first, and only, cycle of virus replication. We report that IFN-b and IFN-c do not inhibit HSV-1 replication via a non-specific cytotoxic effect. Rather, IFN-b and IFN-c render host cells non-permissive for viral DNA synthesis and nucleocapsid assembly, and thus suppress HSV-1 replication in the vast majority of infected cells.
METHODS
Cells, viruses and IFNs. Vero cells, ICP4-complementing E5 cells (DeLuca et al., 1985) , origin-binding protein (OBP)-complementing 2B.11 cells (Malik et al., 1992) and glycoprotein D (gD)-complementing V15-D1 cells (Warner et al., 1998) were propagated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5 % fetal bovine serum (FBS). Wild-type HSV-1 strain KOS (Smith, 1964) was propagated in Vero cells. The ICP4 2 virus n12 (kindly provided by Priscilla Schaffer, Harvard University, USA; DeLuca et al., 1985) , the OBP 2 virus hr94 (Malik et al., 1992) 21 or 300 mM acyclovir. Between 9 and 24 h post-infection (p.i.), crude DNA lysates were harvested and probed for viral DNA and the results were enumerated as described previously (Halford et al., 2005a) . , 100 U each of IFN-b and IFN-c ml 21 or 300 mM acyclovir. Uninfected cells or KOS-infected cells were harvested by aspirating culture medium, rinsing with 1 ml PBS, dissociation in trypsin, resuspension in PBS with 10 % FBS and passing cells through a 50 mm mesh to remove cell debris. Cells were counted for a fixed period of time (2 min) on a FACSCalibur (BD Biosciences). At each time point, the total number of cells in four cultures was determined by using a haemocytometer and compared with the number of cells counted by the flow cytometer. On average, the flow cytometer counted~40 % of cells in these cultures. Therefore, the total number of morphologically normal cells per culture was estimated by dividing the number of cells counted by the flow cytometer by the fraction of cells sampled (e.g.~0?4).
Two-colour analysis of viral protein expression in HSV-1-infected cells. Vero cells were established at a density of 4?5610 6 cells per 100 mm dish and infected with KOS at an m.o.i. of 2?5. At 9 h p.i., Vero cells were dissociated with trypsin and prepared for immunofluorescent labelling by fixation in 2 % formaldehyde with 2 % sucrose, permeabilization in 90 % methanol, passage through a 27-gauge needle and resuspension in PBS plus 0?5 % FBS containing Fc-c-receptor blocking agents (i.e. 5 mg each of human IgG, donkey IgG and goat IgG ml 21 ). Cells were incubated for 1 h with a 1 : 20 000 dilution of rabbit anti-HSV-1 (Dako Cytomation) and a 1 : 1000 dilution of mouse mAb against ICP0, ICP4, ICP6, gC or gD (Rumbaugh Goodwin Institute). Cells were washed twice and incubated for 30 min with a 1 : 1000 dilution of phycoerythrin (PE)-labelled donkey anti-rabbit IgG and a 1 : 350 dilution of fluorescein isothiocyanate (FITC)-labelled goat anti-mouse IgG. Cells were washed twice and the fluorescent intensity of~10 000 cells was measured in each sample (i.e. 10 000 events) by using a FACSCalibur and CellQuest Pro software (BD Biosciences). ICP8 was detected by the same methodology, but cells were labelled singly by incubating for 1 h with a 1 : 20 000 dilution of rabbit polyclonal anti-ICP8 antibody (generously donated by William Ruyechan, State University of New York, Buffalo, USA). For each viral protein, total protein yield was summed by multiplying the fraction of viral protein-positive cells by the mean fluorescent intensity of viral protein staining and this 'fluorescent volume' was normalized relative to the lower limit of detection of the assay, which was defined as three times the background fluorescent volume associated with uninfected cells (Soboleski et al., 2005) . , 100 U each of IFN-b and IFN-c ml 21 or 300 mM acyclovir. Cells were prepared for transmission electron microscopy at 18 h p.i. as described previously (Foster et al., 2003 (Foster et al., , 2004 .
For analysis of virion yields, cells were transferred to 280 uC at 18 h p.i. and virion yields were determined in cell lysates following purification through a series of two gradients. For each sample, 15 fractions that spanned the 30-60 % sucrose interface of the second gradient were identified by using a refractometer, and virion yield in each fraction was measured by ELISA. Each fraction was diluted 1 : 10, 1 : 50 or 1 : 250 in PBS, and each dilution was used as coating antigen in two wells of a 96-well plate. After overnight incubation, virion fractions were discarded, wells were blocked with 0?5 % dried milk and a 1 : 600 dilution of anti-HSV-1 conjugated to horseradish peroxidase (Dako Cytomation) was added per well. After 1 h, excess antibody was rinsed away and bound antibody was measured with TMB Blue substrate (Dako Cytomation; A 450 ) in a plate reader. , 100 U each of IFN-b and IFN-c ml 21 or 300 mM acyclovir had no effect on cell morphology (Fig. 1b) . However, treatments that contained IFN-b prevented proliferation to the same extent as vehicle-treated cells. By comparison, other compounds used to inhibit HSV-1 replication, such as 10 mM MG132 (Poon et al., 2002) or 100 mM roscovitine (Schang et al., 1998) , were overtly toxic to uninfected Vero cells within 24 h (not shown).
Infection with HSV-1 strain KOS (m.o.i. of 2?5) destroyed 99 % of vehicle-treated cells by 48 h p.i. (Fig. 1c) . Treatment with IFN-b or IFN-c delayed the onset of CPE in KOSinfected cultures and increased the fraction of normal cells recovered between 24 and 48 h p.i. (Fig. 1c) . Acyclovir or a combination of IFN-b and IFN-c provided the greatest protection, such that, in these treatment groups,~30 % of KOS-infected cells remained morphologically normal at 48 h p.i. (Fig. 1c) . Therefore, treatment with IFN-b and/or IFN-c was not cytotoxic to Vero cells, but rather delayed the onset of viral CPE in KOS-infected cells.
IFN-b and IFN-c synergistically reduce the efficiency of HSV-1 DNA synthesis
The combined versus separate effects of IFN-b and IFN-c on HSV-1 DNA synthesis were compared in Vero cells inoculated with HSV-1 strain KOS (m.o.i. of 2?5). DNA samples harvested at 9-24 h p.i. were immobilized on a nylon membrane and hybridized to a probe specific for the HSV-1 US6 gene (Fig. 2a) . Treatment with 200 U IFN-b or IFN-c ml 21 alone delayed the detection of viral DNA synthesis by approximately 3 h and slightly decreased the rate (slope) of viral DNA synthesis between 15 and 24 h p.i. relative to vehicle-treated controls ( Fig. 2a and b) . Combined treatment with 100 U each of IFN-b and IFN-c ml 21 delayed the detection of viral DNA synthesis by 6 h and greatly reduced the rate of HSV-1 DNA synthesis ( Fig. 2a and b ; P<0?001, as determined by one-way ANOVA and Tukey's post hoc t-test). Unlike IFN-b and IFN-c, which only reduced the efficiency of HSV-1 DNA synthesis, 300 mM acyclovir prevented the detection of HSV-1 DNA synthesis completely ( Fig. 2a and b) .
IFN-b and IFN-c synergistically reduce the accumulation of HSV-1 mRNAs
The combined versus separate effects of IFN-b and IFN-c on HSV-1 mRNA synthesis were compared in Vero cells inoculated with HSV-1 strain KOS (m.o.i. of 2?5). RNA samples harvested at 9 h after inoculation were compared by Northern blot analysis. In vehicle-treated cells, KOS infection reduced the amount of probe that hybridized to cellular glyceraldehyde-3-phosphate dehydrogenase (G3PDH) mRNA to 15 % of that observed in uninfected Vero cells (Fig. 3) . In KOS-infected cells treated with IFN-b or IFN-c, G3PDH mRNA levels were~50 % of normal levels. However, G3PDH mRNA levels remained at 100 % of normal levels in KOS-infected cells treated with IFN-b and IFN-c or with 300 mM acyclovir (Fig. 3) . Northern blot analysis of viral IE or early (E) mRNAs revealed that IFN-b or IFN-c had little effect on the abundance of ICP4, ICP27, ICP0 or HSV DNA polymerase (pol) mRNAs in KOSinfected Vero cells (Fig. 3) . However, treatment with IFN-b and IFN-c or with 300 mM acyclovir reduced the amount of probe that hybridized to ICP4, ICP27, ICP0 and pol mRNAs by two-to threefold (Fig. 3) . Treatment with IFN-b or IFNc alone caused a one-to threefold reduction in the amount of probe that hybridized to viral late (L) mRNAs that encoded VP5, VP23 or gD (Fig. 3) . Treatment with IFN-b and IFN-c or with 300 mM acyclovir caused a five-to 10-fold reduction in the amount of probe that hybridized to these L viral mRNAs (Fig. 3) . The degree to which IFN-b and IFN-c reduced viral mRNA levels was equivalent to that achieved by 300 mM acyclovir. Thus, the acyclovir control suggested that a block in the amplification of the number of genomes available for mRNA synthesis might contribute significantly to the reduced viral mRNA levels observed in KOS-infected cells treated with IFN-b and IFN-c.
IFN-b and IFN-c synergistically reduce the accumulation of HSV-1 proteins
Flow cytometry was used to compare the combined versus separate effects of IFN-b and IFN-c on the expression of individual HSV-1 proteins in Vero cells inoculated with KOS (m.o.i. of 2?5). Cells were labelled doubly with mAbs against individual viral proteins (e.g. ICP0, ICP4, ICP6 or gD) and rabbit polyclonal antibody against HSV-1, which served as an internal control for the consistency of antibody labelling. Irrelevant mouse antibodies or irrelevant rabbit antibodies failed to label KOS-infected cells (not shown). As 
expected, the ICP4
2 virus n12 expressed high levels of ICP0 ( Fig. 4a and b ) and the N-terminal 251 aa of ICP4 (DeLuca & Schaffer, 1987) , to which the ICP4 antibody binds (Hubenthal-Voss et al., 1988) (Fig. 4c and d) . The ICP4 2 virus expressed only low levels of ICP6 (Fig. 4e and f) and undetectable levels of gD ( Fig. 4g and h ). In contrast, OBP 2 and gD 2 viruses expressed high levels of these viral proteins (Fig. 4a-f ) with the exception of the gD 2 virus, which failed to express gD ( Fig. 4g and h ).
KOS-infected cells treated with vehicle expressed the IE proteins ICP0 and ICP4 at levels that were 80-and 130-fold above the lower limit of detection ( Fig. 4a and c) . Treatment with 200 U IFN-b ml 21 or 200 U IFN-c ml 21 reduced ICP0 and ICP4 abundance by 1?1-to 1?8-fold relative to vehicletreated cells, whereas 100 U ml 21 each of IFN-b and IFN-c reduced ICP0 and ICP4 abundance by 2?5-and 3?3-fold, respectively ( Fig. 4a and c) . Most of the change in ICP0 and ICP4 abundance was not due to differences in protein level per cell (as measured by mean fluorescent intensity), but rather was due to the fact that IFN-b and IFN-c decreased the frequency of KOS-infected cells that were ICP0 + or ICP4
+ by 70 and 60 %, respectively ( Fig. 4b and d) . IFN-b and IFN-c caused a 5?1-fold reduction in the abundance of the E protein ICP6 relative to vehicle-treated cells (Fig. 4e) , which was largely attributable to a 75 % decrease in the frequency of ICP6 + cells (Fig. 4f) . Analysis of ICP8 expression (an E protein) revealed a similar pattern (not shown). IFN-b and IFN-c caused a 7?0-fold reduction in the abundance of the leaky L protein gD relative to vehicle-treated, KOS-infected cells (Fig. 4g) . This decrease was not only due to a 75 % decrease in the frequency of gD + cells (Fig. 4h ), but was also compounded by a 45 % reduction in gD protein per cell (as measured by mean fluorescent intensity). IFN-b and IFN-c caused a 27-fold reduction in the abundance of the true L protein gC relative to vehicle-treated, KOSinfected cells (not shown). This decrease was due to a 94 % decrease in the frequency of gC + cells and a 40 % reduction in gC protein per cell. Flow-cytometric analysis suggested that IFN-b and IFN-c acted at two levels to (i) prevent detectable viral IE and E protein synthesis in~70 % of KOS-infected cells (e.g. as measured by reduced frequency of ICP0
+ cells) and (ii) restrict virus replication in the remaining~30 % of KOS-infected cells in a manner that did not affect viral IE and E protein synthesis. Fig. 5a and b ) and viral titres (Fig. 5c ). Relative to vehicle-treated cells, a combination of IFN-b and IFN-c reduced HSV-1 DNA yields in KOS-infected cells by~100-fold, which was equivalent to the reduction achieved by 32 mM acyclovir ( Fig. 5a and b) . The same combination of IFN-b and IFN-c reduced infectious viral titres by~1000-fold relative to vehicle-treated cells and 32 mM acyclovir was found to reduce viral titres to precisely the same extent (Fig. 5c ). Regression analysis of viral titres versus DNA yield confirmed that acyclovir, an acyclic guanosine analogue (Elion, 1983) , reduced HSV-1 titres in direct proportion to the drug's inhibitory effect on viral DNA synthesis (closed circles in Fig. 5d ). Likewise, it was observed that IFN-b alone, IFN-c alone or IFN-b and IFN-c each reduced HSV-1 titres in direct proportion to their inhibitory effects on HSV-1 DNA synthesis (open symbols in Fig. 5d) . Therefore, the results suggested that IFN-b and/or IFN-c must achieve their full inhibitory effect on HSV-1 replication before or during the process of viral DNA synthesis.
IFN-b and IFN-c synergistically inhibit HSV-1 virion synthesis
The combined versus separate effects of IFN-b and IFN-c on HSV-1 virion synthesis were compared in Vero cells inoculated with HSV-1 strain KOS (m.o.i. of 2?5) and harvested at 18 h p.i. Cellular sections were analysed by transmission electron microscopy. No structures resembling nucleocapsids or enveloped virions were observed in uninfected cells or KOS-infected cells treated with 300 mM acyclovir (not shown). In KOS-infected cells treated with vehicle, enveloped virions were apparent on most cell surfaces (Fig. 6a) . Treatment with IFN-b or IFN-c alone reduced the nucleocapsid density per cell, but viral particles were still evident in >95 % of cell sections (Fig. 6b and c) . In contrast, treatment with IFN-b and IFN-c inhibited virion formation and preserved the ultrastructural features of these cells (e.g. the intact Golgi apparatus in Fig. 6d ). Fewer than 3 % of sections from cells treated with IFN-b and IFN-c contained visible evidence of infection. In the few cells in which virus was observed, only one to five enveloped virions were observed in the cytoplasm or at the cell surface (Fig. 6d) .
The combined versus separate effects of IFN-b and IFN-c on HSV-1 virion yield were enumerated. At 18 h p.i., cells from each treatment group were subjected to freeze-thaw and the released virions were purified over a series of two discontinuous sucrose gradients. Fractions from the interface between the 30 and 60 % layers of the second gradient were used as coating antigens in an ELISA and the capacity of each fraction to capture polyclonal anti-HSV-1 antibody was measured (Fig. 7a) . The results of two independent experiments demonstrated that the yield of HSV-1 virions in vehicle-treated cells was~225 times greater than the background level of the assay (Fig. 7b) .
The yield of HSV-1 virions obtained from cells treated with IFN-b or IFN-c was 29 and 46 % of that recovered from vehicle-treated cells, respectively (Fig. 7b ). In contrast, in cells treated with IFN-b and IFN-c, HSV-1 virion yield was only 2 % of that recovered from vehicletreated cells (Fig. 7b) . Therefore, combinations of IFN-b and IFN-c repressed HSV-1 virion synthesis to a much greater extent than could be achieved with either IFN-b or IFN-c alone. morphology. Therefore, we inferred that combinations of IFN-b and IFN-c suppressed HSV-1 replication noncytolytically via the disruption of productive virus replication.
Are the effects of IFN-b and IFN-c on HSV-1 replication synergistic?
Pharmacological analysis of synergy focuses on differentiating whether an observed change in effect is due to (i) a cooperative interaction between two biologically active agents or (ii) the change in concentration that occurs whenever two agents are combined. Under a null hypothesis of dose additivity, IFN-b and IFN-c would be assumed to have purely redundant effects, such that 100 U each of IFN-b and IFN-c ml 21 should inhibit any step of HSV-1 replication to the average level of that achieved by 200 U IFN-b ml 21 or 200 U IFN-c ml 21 (Tallarida, 2001; Tallarida et al., 1997) . The observed effects of IFN-b and IFN-c were compared with the predictions of the null hypothesis (Table 1) . In each case, IFN-b and IFN-c reduced the synthesis of viral proteins, viral DNA and virions to an extent far greater than that predicted by the null hypothesis. Thus, the block in HSV-1 replication that was produced by co-activation of the IFN-a/ b and IFN-c pathways was quantitatively distinct from that which occurred when only one of these two signalling pathways was activated. The multiplicative nature of the interaction between the IFN-a/b and IFN-c pathways is considered in detail elsewhere (Halford et al., 2005a) .
Where do IFN-b and IFN-c act to inhibit HSV-1 replication?
Viral mutants or acyclovir were used to help break down the complex process of HSV-1 replication into discernible phases. The phenotypes that followed from failure to exit the IE phase of gene expression were defined by the ICP4 2 virus, n12 (DeLuca et al., 1985) . The consequences of a block in viral DNA synthesis were defined by the OBP 2 virus hr94 (Malik et al., 1992) or treatment of KOS-infected cells with 300 mM acyclovir (Elion, 1983) .
Inhibition of viral IE gene expression? Cells infected with an ICP4
2 virus expressed five times as much ICP0 as KOS-infected cells treated with IFN-b and IFN-c. However, ICP4
2 virus-infected cells expressed low levels of ICP6 and undetectable levels of gD. In contrast, KOSinfected cells treated with IFN-b and IFN-c exhibited a more gradual attenuation of E and L protein synthesis (i.e. ICP6, ICP8, gC and gD). Relative to the ICP4 2 virus, viral E and L proteins were far too abundant in IFNtreated, KOS-infected cells for repression of viral IE protein synthesis to be the sole mechanism by which IFN-b and IFN-c inhibit HSV-1 replication.
Inhibition of viral DNA synthesis? IFN-b and IFN-c did not block viral DNA synthesis in KOS-infected cells with the efficiency of 300 mM acyclovir. However, IFN-b and IFN-c caused a greater reduction in viral IE and E protein synthesis than acyclovir treatment of KOSinfected cells. Likewise, an OBP 2 virus expressed high levels of ICP0, ICP4, ICP6 and ICP8, despite a complete block in viral DNA synthesis. Relative to these controls, viral IE and E protein expression was far too restricted in IFN-treated, KOS-infected cells for repression of viral DNA synthesis to be the sole mechanism by which IFN-b and IFN-c inhibited HSV-1 replication. IFN-b and IFN-c do not inhibit HSV-1 at the same step in every infected cell. Flow-cytometric analysis of viral protein expression revealed that IFN-b and IFN-c must inhibit KOS replication at at least two distinct points. The first point of inhibition produced by IFN-b and IFN-c reduced the frequency of KOS-infected cells that expressed detectable levels of ICP0 by 70 % relative to vehicle-treated cells (Fig. 4) . Because IFN-b and IFN-c do not preclude viral entry , we inferred that IFN-b and IFN-c repressed viral ICP0 gene expression successfully in~70 % of KOS-infected cells. Absence of ICP0 renders viral IE genes highly susceptible to repression by IFN-a/b (Härle et al., 2002; Mossman et al., 2000) . Thus, whether or not ICP0 is synthesized may create two divergent outcomes of HSV-1 infection.
Under this hypothesis, one would predict that, if IFN-b and IFN-c repress the ICP0 gene in~70 % of KOSinfected cells, then all viral IE and E gene expression will be repressed in this subpopulation of cells (Mossman et al., 2000) . However, if IFN-b and IFN-c fail to repress the ICP0 gene in~30 % of KOS-infected cells, the resulting ICP0 protein that is synthesized will destabilize IFNinduced repression of viral IE genes (Härle et al., 2002) and thus allow virus replication to proceed beyond this first restriction point. Although this hypothesis is highly consistent with the results, its validity remains to be tested.
The second discernible point of inhibition produced by IFN-b and IFN-c lies at the level of viral DNA synthesis. The relative to vehicle-treated controls. Mean±SEM fold reduction in ICP0, ICP4, ICP6, gC or gD proteins at 9 h p.i. (n=3 per group). Based on flow-cytometric analysis of each protein using mouse mAbs as the primary label and FITC-labelled goat anti-mouse IgG as the secondary label. These conclusions are based on the data presented in Fig. 4 with the exception of the gC data, which are not shown. The kinetic class of each viral protein is indicated in parentheses (IE, E or L). #Mean±SEM fold reduction in ICP8 protein at 9 h p.i. (n=3 per group). Based on flow-cytometric analysis using rabbit polyclonal anti-ICP8 as the primary label and PE-labelled donkey anti-rabbit IgG as the secondary label (data not shown). **Mean±SEM fold reduction in relative DNA yield at 18 h p.i. (n=3 per group). Based on results presented in Fig. 5 . DDMean±SD fold reduction in virion yield at 18 h p.i. (n=2 per group). Based on results presented in Fig. 7 . ddNA, Not applicable. The number of independent tests (n=2) was insufficient for statistical comparison of the summed value of total virion yield by the paired t-test used in this table. It should be noted that an appropriate statistical analysis of the 30 gradient fractions tested per group (e.g. two-way ANOVA) would indicate that the null hypothesis, H 0 : P2O=0, should be rejected. 50-to 100-fold reduction in viral DNA synthesis that was produced by IFN-b and IFN-c would not be predicted based on the fact that~25 % of KOS-infected cells (relative to vehicle-treated controls) expressed normal levels of the E proteins ICP6 and ICP8 at 9 h p.i. The underlying mechanism that accounts for the block in viral DNA synthesis induced by IFN-b and IFN-c remains to be elucidated and will certainly be the focus of future investigation. Given the hypersensitivity of HSV-1 ICP34?5 2 mutants to IFN-a/b (Cerveny et al., 2003; Mossman & Smiley, 2002) , one intriguing possibility is that expression of the other major viral IFN antagonist, ICP34?5, is repressed synergistically by IFNb and IFN-c such that HSV-1 is rendered highly susceptible to a protein kinase-induced shutoff of L viral protein translation (Leib et al., 2000) . The validity of this specific hypothesis remains to be tested. 
Relevance of the experimental design
In nature, animals are first infected with a virus and then respond by secreting cytokines such as IFN-a/b or IFN-c. Given the natural order of events, what natural process is being modelled when Vero cells are pre-treated with IFN-b and IFN-c for 16 h prior to infection? At the time at which HSV-1 first infects an animal, IFNs are absent in host tissues and the first productive cycle of virus replication proceeds unhindered in vivo. However, the available evidence suggests that host IFNs play a pivotal role in restricting the efficiency with which each of the approximately ten subsequent cycles of virus replication proceed during a typical 7 day course of acute infection in vivo (Halford et al., 2005b; Luker et al., 2003; Vollstedt et al., 2004) . Thus, the natural process being modelled when Vero cells are pre-treated with IFN-b and IFN-c relates to the pivotal role that host IFNs play in restricting HSV-1 spread within infected tissues in vivo.
Conclusion
Co-activation of the IFN-a/b and IFN-c signalling pathways produces a multiplicative inhibition of HSV-1 replication (Halford et al., 2005a) . Studies in IFN-receptor knockout mice corroborate the functional relevance of this interaction in vivo (Luker et al., 2003; Vollstedt et al., 2004) . Given the persistence of IFN-c-expressing CD8
+ T cells at sites of latent HSV-1 infection (Khanna et al., 2003; Theil et al., 2003) , these results suggest that IFN-c secretion may contribute to the capacity of CD8 + T cells to protect HSV-1-infected neurons from viral CPE (Simmons & Tscharke, 1992) . Although the current study offers only limited insight into the real mechanism of IFN-induced inhibition of HSV-1 replication, the results provide an empirical basis to focus on the relevant possibilities. We conclude that any viable hypothesis must be constrained by the facts that coactivation of the IFN-a/b and IFN-c signalling pathways (i) does not compromise host-cell viability, (ii) prevents detectable viral IE and E protein synthesis in two-thirds of HSV-1-infected cells, (iii) blocks viral DNA synthesis in the remaining one-third of HSV-1-infected cells and (iv) effectively prevents the synthesis of new infectious virions.
